TRPV4 ANTAGONISTS
A combination comprising a compound of Formula (I): or a pharmaceutically acceptable salt thereof; and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, va...
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.04.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A combination comprising a compound of Formula (I):
or a pharmaceutically acceptable salt thereof;
and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective ²-adrenoceptor and ± 1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors. |
---|---|
AbstractList | A combination comprising a compound of Formula (I):
or a pharmaceutically acceptable salt thereof;
and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective ²-adrenoceptor and ± 1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors. |
Author | HAMMOND, MARLYS HILFIKER, MARK, A HOANG, TRAM, H GOODMAN, KRISTA, B EIDAM, HILARY, SCHENCK YE, GUOSEN CHEUNG, MUI STOY, PATRICK BROOKS, CARL PATTERSON, JACLYN, R |
Author_xml | – fullname: PATTERSON, JACLYN, R – fullname: EIDAM, HILARY, SCHENCK – fullname: HILFIKER, MARK, A – fullname: BROOKS, CARL – fullname: CHEUNG, MUI – fullname: STOY, PATRICK – fullname: YE, GUOSEN – fullname: HOANG, TRAM, H – fullname: GOODMAN, KRISTA, B – fullname: HAMMOND, MARLYS |
BookMark | eNrjYmDJy89L5WQQDAkKCDNRcPQLcXT39_MMDgnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgFG5kaGBoZmTobGRCgBAK8FHzE |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | ANTAGONISTES DE TRPV4 TRPV4-ANTAGONISTEN |
ExternalDocumentID | EP2721016B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP2721016B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:57:19 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP2721016B13 |
Notes | Application Number: EP20120814591 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160406&DB=EPODOC&CC=EP&NR=2721016B1 |
ParticipantIDs | epo_espacenet_EP2721016B1 |
PublicationCentury | 2000 |
PublicationDate | 20160406 |
PublicationDateYYYYMMDD | 2016-04-06 |
PublicationDate_xml | – month: 04 year: 2016 text: 20160406 day: 06 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED |
RelatedCompanies_xml | – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED |
Score | 3.0278175 |
Snippet | A combination comprising a compound of Formula (I):
or a pharmaceutically acceptable salt thereof;
and one or more other therapeutic agents, selected from the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
Title | TRPV4 ANTAGONISTS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160406&DB=EPODOC&locale=&CC=EP&NR=2721016B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMQFWusCOhQlor5OlrklqqoFuoolxiq5hchow_ZhYmKSlgGZ0ff3MPEJNvCJMI5gYMmF7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHdsaAZMk2ZqLk62rgH-Lv7Oas7OQJaaX5CtEdBBQGknYEeJFdiKNgdlBtcwJ9CmlALkGsVNkIEtAGhYXokQA1NqnjADpzPs4jVhBg5f6Hw3kAnNesUiDIIhQQFhJgqOfiGO7v5-nsEhwaIMCm6uIc4eukCz4-H-iHcNgLvCWIyBBdi9T5VgUDA3NzZPM0hKNkw2SDMxTEtOTDJItTQ3NU9JAzalzFITJRkkcRojhUdOmoELFCDgVSZmMgwsJUWlqbLACrQkSQ7sdQBsdnFr |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzJoGYtzGADGePaDeKlqaNexQofVFB-tDW5h2q_pIpF22iRXx-7hVN7jAzUoky7Hs2I4fAbgnaHQxsCBVr9NQIZyrSkr0QtFygfJDnogoqoxuEBr-O3ldDBYtWO56Yeo5oV_1cETUqBz1vazv683PI5ZT11ZuH7IlLq2fPWY6chMdawbKpCE7lunGkRPZsm0jJIdT8xEJwm0LA6UD9LBppQzu3KqaUja_LYrXhcMYka3KE2jxVQ869u7jtR4cBU2-G8FG9ban0GXTeE6kUchGL1E4nrHZGUiey2xfQdzJ_hyJG--p0M-hjeE9vwCJUp0KNcu1XBVEE3maqXxIB7QQ6EoZPO1D_080l__s3UHHZ8EkmYzDtys4rphTV5wY19AuPz75DRrTMrut2fAN6AJ0Xg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRPV4+ANTAGONISTS&rft.inventor=PATTERSON%2C+JACLYN%2C+R&rft.inventor=EIDAM%2C+HILARY%2C+SCHENCK&rft.inventor=HILFIKER%2C+MARK%2C+A&rft.inventor=BROOKS%2C+CARL&rft.inventor=CHEUNG%2C+MUI&rft.inventor=STOY%2C+PATRICK&rft.inventor=YE%2C+GUOSEN&rft.inventor=HOANG%2C+TRAM%2C+H&rft.inventor=GOODMAN%2C+KRISTA%2C+B&rft.inventor=HAMMOND%2C+MARLYS&rft.date=2016-04-06&rft.externalDBID=B1&rft.externalDocID=EP2721016B1 |